Curis Current Ratio 2006-2021 | CRIS

Curis current ratio from 2006 to 2021. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Curis Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2021-06-30 $0.16B $0.01B 19.90
2021-03-31 $0.16B $0.01B 23.15
2020-12-31 $0.17B $0.01B 17.14
2020-09-30 $0.03B $0.01B 3.10
2020-06-30 $0.03B $0.01B 2.92
2020-03-31 $0.02B $0.01B 2.76
2019-12-31 $0.03B $0.01B 3.82
2019-09-30 $0.03B $0.01B 6.93
2019-06-30 $0.04B $0.00B 8.77
2019-03-31 $0.05B $0.01B 9.81
2018-12-31 $0.03B $0.01B 2.11
2018-09-30 $0.04B $0.01B 2.63
2018-06-30 $0.04B $0.02B 3.01
2018-03-31 $0.05B $0.01B 3.60
2017-12-31 $0.06B $0.01B 4.56
2017-09-30 $0.07B $0.01B 5.15
2017-06-30 $0.05B $0.02B 3.72
2017-03-31 $0.06B $0.01B 5.86
2016-12-31 $0.05B $0.01B 3.56
2016-09-30 $0.06B $0.01B 4.54
2016-06-30 $0.07B $0.01B 5.70
2016-03-31 $0.08B $0.01B 6.35
2015-12-31 $0.09B $0.01B 7.95
2015-09-30 $0.10B $0.01B 10.38
2015-06-30 $0.10B $0.01B 11.28
2015-03-31 $0.10B $0.01B 10.54
2014-12-31 $0.05B $0.01B 5.19
2014-09-30 $0.06B $0.01B 5.81
2014-06-30 $0.06B $0.01B 6.15
2014-03-31 $0.06B $0.01B 7.64
2013-12-31 $0.06B $0.01B 9.17
2013-09-30 $0.07B $0.01B 11.35
2013-06-30 $0.06B $0.01B 10.89
2013-03-31 $0.05B $0.00B 14.23
2012-12-31 $0.06B $0.00B 14.29
2012-09-30 $0.04B $0.00B 10.59
2012-06-30 $0.05B $0.00B 13.01
2012-03-31 $0.05B $0.00B 12.14
2011-12-31 $0.04B $0.00B 10.17
2011-09-30 $0.03B $0.00B 8.38
2011-06-30 $0.03B $0.00B 9.83
2011-03-31 $0.04B $0.00B 11.45
2010-12-31 $0.04B $0.00B 11.82
2010-09-30 $0.05B $0.00B 17.87
2010-06-30 $0.05B $0.00B 25.89
2010-03-31 $0.05B $0.00B 22.73
2009-12-31 $0.03B $0.00B 8.66
2009-09-30 $0.03B $0.00B 7.97
2009-06-30 $0.03B $0.00B 12.53
2009-03-31 $0.03B $0.00B 15.63
2008-12-31 $0.03B $0.00B 11.34
2008-09-30 $0.03B $0.00B 12.00
2008-06-30 $0.03B $0.00B 13.42
2008-03-31 $0.04B $0.00B 12.52
2007-12-31 $0.04B $0.01B 6.34
2007-09-30 $0.04B $0.00B 9.99
2007-06-30 $0.03B $0.01B 6.52
2007-03-31 $0.04B $0.01B 7.35
2006-12-31 $0.04B $0.01B 6.43
2006-09-30 $0.04B $0.01B 5.88
2006-06-30 $0.04B $0.01B 4.20
2006-03-31 $0.05B $0.01B 5.01
2005-12-31 $0.05B $0.01B 4.64
2005-09-30 $0.05B $0.01B 4.63
2005-06-30 $0.05B $0.01B 4.65
2005-03-31 $0.05B $0.01B 5.84
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.624B $0.011B
Curis, Inc. is a therapeutic drug development company focusing on cancer, neurological and dermatological disease indications, with technologies that utilize regulatory pathways that control repair and regeneration. Curis' product development involves the use of small molecules or proteins to modulate these pathways. The company has successfully used this technology and product development approach to produce several promising drug product candidates in the fields of cancer, neurological disorders, hair growth, kidney and other diseases, as well as cardiovascular disease.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $129.416B 8.62
Bio-Rad Laboratories (BIO.B) United States $21.730B 46.31
QIAGEN (QGEN) Netherlands $12.526B 21.21
Biohaven Pharmaceutical Holding (BHVN) United States $9.249B 0.00
Emergent Biosolutions (EBS) United States $2.705B 6.53
Arcus Biosciences (RCUS) United States $2.404B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.873B 0.00
Myovant Sciences (MYOV) United Kingdom $1.831B 0.00
Zymeworks (ZYME) Canada $1.080B 0.00
Ambrx Biopharma (AMAM) United States $0.464B 0.00
SQZ Biotechnologies (SQZ) United States $0.372B 0.00
Enzo Biochem (ENZ) United States $0.161B 15.86